1995
DOI: 10.1016/0006-8993(95)00791-n
|View full text |Cite
|
Sign up to set email alerts
|

Neurokinin-3 receptors modulate dopamine cell function and alter the effects of 6-hydroxydopamine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
25
1

Year Published

1996
1996
2009
2009

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 37 publications
(27 citation statements)
references
References 34 publications
1
25
1
Order By: Relevance
“…NK3 receptors have been demonstrated on dopaminergic neurons in the substantia nigra (SN) and ventral tegmental area (VTA) (Stoessl 1994;Langlois et al 2001). Activation of this receptor modulates the release of dopamine (Stoessl et al 1991;Bannon et al 1995). Senktide, a NK3 receptor agonist, has also been shown to excite dopaminergic neurons in the SN and VTA (Keegan et al 1992;Seabrook et al 1995).…”
Section: Discussionmentioning
confidence: 97%
See 2 more Smart Citations
“…NK3 receptors have been demonstrated on dopaminergic neurons in the substantia nigra (SN) and ventral tegmental area (VTA) (Stoessl 1994;Langlois et al 2001). Activation of this receptor modulates the release of dopamine (Stoessl et al 1991;Bannon et al 1995). Senktide, a NK3 receptor agonist, has also been shown to excite dopaminergic neurons in the SN and VTA (Keegan et al 1992;Seabrook et al 1995).…”
Section: Discussionmentioning
confidence: 97%
“…Based on these data, localization studies, and the pharmacological effects of tachykinin ligands, the NK3 receptor has been suggested to play a role in schizophrenia (Meltzer and Prus 2006), Parkinson's disease (Bannon et al 1995;Chen et al 2004), epilepsy (Roder et al 1994), anxiety (Ribeiro et al 1999;Hasenohrl et al 2000), depression (Panocka et al 2001), and memory and reinforcement related processes Huston et al 1993;Krappmann et al 1994).…”
Section: Introductionmentioning
confidence: 98%
See 1 more Smart Citation
“…7 The soluble carrier family six dopamine transporter member three gene (DAT, locus symbol: SLC6A3) codes for a dopamine transporter protein (DAT), which limits the level and duration of dopamine receptor activation. 8 The mouse model of dopamine transporter gene knockout established not only the central importance of dopamine transporter in controlling synaptic dopamine levels, but also its role as an obligatory target for the behavioral and biochemical action of amphetamine and cocaine. 9 Vandenbergh et al 10 identified several polymorphisms in DAT1, including a polymorphic 40 bp repeat in the transcribed portion of the gene, which is most commonly observed repeat 9 (DAT1*9R) to 10 times (DAT1*10R).…”
Section: Introductionmentioning
confidence: 99%
“…Compared with the NK 1 and NK 2 receptors, much less is known about the biological function of the NK 3 receptor. NK 3 receptors are mainly distributed in the central nervous system (4), and NKB has the highest affinity to this receptor subtype. With the recent development of selective NK 3 antagonists (5,6), it is expected that the biological function of the NK 3 receptor will be elucidated in the near future.…”
mentioning
confidence: 99%